Netherlands vs New Zealand: Immunization, Hib3
Netherlands
89.0%
in 2024
New Zealand
89.0%
in 2024
Netherlands rank
108th
New Zealand rank
108th
Immunization, Hib3 over time
- Netherlands
- New Zealand
How they compare
Netherlands currently reports 89.0% against 89.0% in New Zealand, a difference of 0.0%.
The two have swapped places 3 times across 28 shared years of data; in 1997 it was Netherlands ahead.
Netherlands ranks 108th and New Zealand ranks 108th of 191 countries.
Netherlands has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Netherlands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 96.0% | 85.0% | 11.0% | Netherlands |
| 2000s | 96.5% | 85.8% | 10.7% | Netherlands |
| 2010s | 95.6% | 92.1% | 3.5% | Netherlands |
| 2020s | 91.6% | 89.6% | 2.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Netherlands or New Zealand?
- Netherlands, at 89.0% against 89.0% in New Zealand as of 2024.
- What is the difference in immunization, hib3 between Netherlands and New Zealand?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and New Zealand?
- 28 years are reported by both, from 1997 to 2024.
- How do Netherlands and New Zealand rank globally for immunization, hib3?
- Netherlands ranks 108th and New Zealand ranks 108th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.